Log In
Print
BCIQ
Print
Print this Print this
 

anti-PrP antibody (AMF-1c-120)

  Manage Alerts
Collapse Summary General Information
Company Amorfix Life Sciences Ltd.
DescriptionAntibody-drug conjugate (ADC) composed of an anti-misfolded prion protein (PRNP; PrP; CD230) antibody and urease
Molecular Target Prion protein (PRNP) (PrP) (CD230)
Mechanism of ActionAntibody-drug conjugate
Therapeutic ModalityBiologic: Antibody-drug conjugate
Latest Stage of DevelopmentPreclinical
Standard IndicationOvarian cancer
Indication DetailsTreat ovarian cancer
Regulatory Designation

Partner

Apexigen Inc.


 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today